Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height

Amarin

Amarin reported $244.24M in Current Liabilities for its fiscal quarter ending in March of 2023.


Current Liabilities Change
Alnylam Pharmaceuticals ALNY:US USD 673.39M 94.52M
Amarin AMRN:US USD 244.24M 15.24M
AstraZeneca AZN:LN USD 24.86B 1.43B
DBV Technologies DBVT:US USD 32.78M 3.26M
Esperion Therapeutics ESPR:US USD 95.49M 3.18M
GlaxoSmithKline GSK:LN GBP 20.7B 2.11B
Halozyme Therapeutics HALO:US USD 91.92M 38.87M
Heron Therapeutics HRTX:US USD 77.9M 4.46M
Intercept Pharmaceuticals ICPT:US USD 207.12M 22.96M
Ionis Pharmaceuticals IONS:US USD 259.22M 52.34M
Nektar Therapeutics NKTR:US USD 59.88M 8.32M
Neurocrine Biosciences NBIX:US USD 374.1M 163.6M
Novartis NOVN:VX USD 30.55B 1.89B